Clinical Trials Logo
  1. Home
  2. Tourette's Syndrome
  3. NCT04805385

Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome

Tourette's Syndrome Clinical Trial

Official title:
Effects of Lactobacillus Plantarum PS128 in Patients With Tourette's Syndrome

Clinical Trial Summary

To evaluate whether supplementing with PS128 can improve the symptoms and quality of life related to Tourette's disease in children.

Clinical Trial Description

This is a randomized double-blind healthy control study and the implementation period is after Institutional Review Board (IRB) approval to December 31, 2022. Experimental group: 80 subjects who meet the criteria for the admission of Tourette's disease will be enrolled. They will consume the PS128 or placebo capsules every day, 2 capsules at a time, for 12 weeks. Healthy control group: 40 subjects of the same age as the experimental group will be included, without any intervention measures, only collect stool sample once. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04805385
Study type Interventional
Source China Medical University Hospital
Contact I-Ching Chou, MD
Phone +886 4 22052121
Email iching@mail.cmu.edu.tw
Status Recruiting
Phase N/A
Start date November 29, 2021
Completion date December 31, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00965211 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Safety and Feasibility Study for the Treatment of Tourette Syndrome N/A
Recruiting NCT00152750 - Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD Phase 4
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Terminated NCT00226824 - Safety Study of Galantamine in Tic Disorders Phase 4
Completed NCT01244633 - Ecopipam Treatment of Tourette Syndrome Phase 1/Phase 2
Completed NCT00026000 - Brain Activation in Vocal and Motor Tics N/A
Terminated NCT00001260 - Brain Tissue Collection for Neuropathological Studies
Completed NCT02102698 - Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years Phase 2
Withdrawn NCT02112253 - Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome Phase 1/Phase 2
Withdrawn NCT01133353 - A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome Phase 2
Completed NCT02205918 - Brain-Behavior Interactions in Tic Suppression
Terminated NCT00282139 - Aripiprazole in the Treatment of Tourette's Syndrome N/A
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A
Completed NCT01019343 - Physiological Investigations of Movement Disorders N/A
Completed NCT02619084 - Subthalamic Stimulation in Tourette's Syndrome Phase 2
Completed NCT00368433 - Hypersensitivity in Tourette Syndrome N/A
Withdrawn NCT01475383 - Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome Phase 2
Not yet recruiting NCT06361004 - Exploring DBS Efficacy in Treatment-refractory Tourette's Syndrome N/A
Completed NCT00139308 - High Frequency Stimulation of the GPi or Thalamus in Tourette's Syndrome Phase 1